๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Walvax Biotechnology Co., Ltd. (SHE:300142)
China flag China ยท Delayed Price ยท Currency is CNY
10.00
-0.64 (-6.02%)
Nov 20, 2026, 3:04 PM CST

Walvax Biotechnology Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
1,8462,4182,8214,1145,0863,463
Revenue Growth
-23.03%-14.29%-31.41%-19.12%46.89%17.82%
Gross Profit
1,3191,7862,0793,3644,4133,059
Operating Income
96.35104.3324.01831.051,174792.22
Net Income
21.84177.74142.16419.39728.65427.75
Earnings Per Share
0.010.110.090.260.450.27
EPS Growth
-55.77%24.97%-66.08%-42.32%67.12%-57.74%

Revenue by Geography

Fiscal Year
FY 2025FY 2024
Period EndingDec '25 Dec '24
Northeast and North China
213.01252.42
Eastern China
679.27874.69
South China Region
400.71404.62
Central China Region
256.31332.25
Southwest Northwest Region
346.88387.18
Overseas Region
522.04570.29
Total
2,4182,821

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
906.871,6653,7644,3653,8733,443
Total Debt
1,404388.63491.94806.42462.51315.67
Net Cash (Debt)
-497.311,2763,2723,5583,4113,128
Net Cash Growth
--61.00%-8.05%4.31%9.06%62.77%
Net Cash Per Share
-0.310.802.052.222.131.99

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
764.35490.931,0371,1341,201705.28
Capital Expenditures
-376.17-509.54-550.03-945.52-1,091-1,103
Free Cash Flow
388.18-18.62486.49188.25110.31-398.21
Free Cash Flow Growth
309.35%-158.43%70.65%--

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
71.44%73.87%73.69%81.78%86.77%88.35%
Operating Margin
5.22%4.31%0.85%20.20%23.08%22.88%
Pretax Margin
2.90%6.87%6.54%14.56%21.05%20.47%
Profit Margin
1.18%7.35%5.04%10.20%14.32%12.35%
FCF Margin
21.02%-0.77%17.24%4.58%2.17%-11.50%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.1550.1550.0100.0100.0100.027
Dividend Per Share Growth
1450.00%1450.00%0%0%-62.96%-61.43%
Dividend Yield
1.55%1.42%0.08%0.04%0.03%0.05%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
734.2198.17135.9089.6688.21209.06
Forward PE
-50.1637.7542.7554.6856.13
P/FCF Ratio
41.61-39.71199.74582.65-
PS Ratio
8.757.226.859.1412.6425.82